Dublin, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/79x33j/global_salicylic) has announced the addition of the "Global Salicylic Acid Market 2015-2019" report to their offering.
The global salicylic acid market is predicted to grow at a CAGR of around 9%
The increased use of salicylic acid in the manufacture of aspirin and its extensive application in the pharmaceutical sector is the primary driver for the growth of the market.
The increased preference for preserved food and beverages among consumers is anticipated to contribute to the market growth of salicylic acid during the forecast period. With increasing health consciousness among the global population, consumers are particular about the food they consume and the ingredients used in its processing. The use of salicylic acid in functional foods helps in preventing diabetes, improving health, and treating dermatitis and warts among patients. The demand for functional foods is high in regions such as APAC and North America due to the growing trend of healthy living in these countries.
Pharmaceuticals is expected to account for around 41% of the market share by the end of 2019. Salicylic acid is used in the treatment of diseases such as psoriasis, seborrhoeic dermatitis, and eczema.
EMEA accounted for the around 45% of the market share during 2014. The report anticipates the region to witness a decline in its market shares during the forecast period. The decrease in growth of cosmetics and personal care segment is expected to affect the growth of this region.
The global salicylic acid market is highly competitive due to the influx of private providers into the market. The market is predicted to witness an increased number or mergers and R&D during the forecast period.
Segmentation by application and analysis of the salicylic acid market
- Pharmaceuticals
- Cosmetics
- Food and preservatives
The key vendors in the market are
- Alta Laboratories
- Alfa Aesar
- Novacap
- Sigma-Aldrich
- Zhenjiang Gaopeng
Other prominent vendors in the market include
- J.M. Loveridge
- Siddharth Carbochem
- Rishabh Metals and Chemicals
- Samrat Remedies
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by application
Food, preservative, and others sector
Part 07: Market segmentation by geography
Part 08: Manufacturing process analysis
Part 09: Trade balance analysis
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information visit http://www.researchandmarkets.com/research/79x33j/global_salicylic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Chemicals


Alibaba Stock Surges After Strong Q4 Earnings Boosted by AI and Cloud Growth
Samsung Strike Talks Resume as South Korea Weighs Emergency Action
Samsung Faces Major Strike Threat as Union Restarts Pay Talks
DOJ May Drop Gautam Adani Fraud Charges Amid $10 Billion U.S. Investment Plan
FTC Antitrust Probe Targets Arm Holdings Over Chip Licensing Practices
Elliott Targets Bio-Rad as Shares Continue to Struggle
Berkshire Hathaway Reveals New Stakes in Delta Air Lines and Macy’s Under Greg Abel
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower
BlackRock-Led GCC Infrastructure Partnership Targets $30 Billion Investment
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
Telefónica Q1 2026 Earnings Beat Expectations as Debt Declines and Cash Flow Improves
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge
Nvidia’s China AI Chip Sales Remain Frozen Despite U.S. Approval
Elon Musk’s China Influence Faces New Challenges Amid Rising EV Competition
SoftBank Shares Slide Despite Record Q4 Profit Fueled by OpenAI Investment 



